StockData
Evotec SE logo

Evotec SE (EVO) stock

EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 4/30
$1.46−0.02 (-1.35%)

Close on Nov 18, 2026Market cap $519.11MP/E –Yield –

Evotec cash

Cash and short-term investments held at the end of each period.

Evotec's cash was €418.52M at Dec 31, 2025. For fiscal 2025 it was €418.52M, up 36.6% from the year before. The highest annual figure on record is €699.33M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025€418.52M+36.6%
FY2024Dec 31, 2024€306.39M-40.0%
FY2023Dec 31, 2023€510.91M+23.1%
FY2022Dec 31, 2022€415.16M-40.6%
FY2021Dec 31, 2021€699.33M+65.5%
FY2020Dec 31, 2020€422.58M+52.5%
FY2019Dec 31, 2019€277.03M+154.0%
FY2018Dec 31, 2018€109.06M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025€418.52M-40.2%
Q4 FY2024Dec 31, 2024€306.39M-27.5%
Q4 FY2023Dec 31, 2023€510.91M+84.4%
Q4 FY2022Dec 31, 2022€415.16M+280.7%
Q4 FY2021Dec 31, 2021€699.33M–
Q4 FY2020Dec 31, 2020€422.58M–
Q4 FY2019Dec 31, 2019€277.03M–
Q4 FY2018Dec 31, 2018€109.06M–

More Evotec figures

See a number that looks wrong?